{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_Display\ Name in Display Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
M012
(2024)
Source URL:
First approved in 1999
Source:
ANDA209886
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA103914
(1980)
Source URL:
First approved in 1980
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2025)
Source URL:
First approved in 1956
Source:
ANDA091382
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03530124: Phase 4 Interventional Completed Apnea
(2018)
Source URL:
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE